{
    "2019-09-20": [
        [
            {
                "time": "",
                "original_text": "上海医药(02607-HK)获核准增发不超过约1.84亿股境外上市外资股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "核准",
                        "增发",
                        "境外上市外资股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药(02607.HK)控股股东上实集团增持20万股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股股东",
                        "上实集团",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)非公开发行境外上市外资股(H股)获中国证监会核准",
                "features": {
                    "keywords": [
                        "上海医药",
                        "非公开发行",
                        "境外上市外资股",
                        "H股",
                        "中国证监会",
                        "核准"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}